120. Hungin AP, Raghunath AS, Wiklund I. Beyond heartburn: a systematic review of the extraoesophageal spectrum of reflux-induced disease. Fam Pract 2005;22:591–603.

121. Levin TR, Sperling RM, McQuaid KR. Omeprazole improves peak expiratory flow rate and quality

of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol 1998;93:1060–1063.

122. Boeree MJ, Peters FT, Postma DS, et al. No effects of high-dose omeprazole in patients with severe

airway hyperresponsiveness and symptomatic gastro-oesophageal reflux. Eur Respir J

1998;11:1070–1074.

123. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive

therapy improves asthma outcome. Am J Med 1996;100:395–405.

124. Raghu G, Yang ST, Spada C, et al. Sole treatment of acid gastroesophageal reflux in idiopathic

pulmonary fibrosis: a case series. Chest 2006;129: 794–800.

125. Sontag SJ, O’Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux: long term

results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol

2003;98:987–999.

126. Lau CL, Palmer SM, Howell DN, et al. Laparoscopic antireflux surgery in the lung transplant

population. Surg Endosc 2002;16:1674–1678.

127. Linden PA, Gilbert RJ, Yeap BY, et al. Laparoscopic fundoplication in patients with end-stage lung

disease awaiting transplantation. J Thorac Cardiovasc Surg 2006;131:438–446.

128. Patti MG, Tedesco P, Golden J, et al. Idiopathic pulmonary fibrosis: how often is it really

idiopathic? J Gastrointest Surg 2005;9:1053–1056.

129. Fernando HC, El-Sherif A, Landreneau RJ, et al. Efficacy of laparoscopic fundoplication in

controlling pulmonary symptoms associated with gastroesophageal reflux disease. Surgery

2005;138:612–616.

130. Spechler SJ. The columnar lined esophagus: history, terminology and clinical issues. Gastroenterol

Clin North Am 1997;26:455–466.

131. Peters JH, Hagen JA, DeMeester SR. Barrett’s esophagus. J Gastrointest Surg 2004;8:1–17.

132. Chandrasoma P. Norman Barrett: so close, yet 50 years away from the truth. J Gastrointest Surg

1999;3:7–14.

133. Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett’s esophagus: multivariate

analyses of 502 patients with GERD. Arch Surg 2001;136:1267–1273.

134. Kauer WK, Stein HJ. Bile reflux in the constellation of gastroesophageal reflux disease. Thorac Surg

Clin 2005;15:335–340.

135. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control

of acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol 1994;89:989–991.

136. Ouatu-Lascar R, Triadafilopolous G. Complete elimination of reflux symptoms does not guarantee

normalization of intraesophageal acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol

1998;93:711–716.

137. Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett’s esophagus with acid suppression and

multipolar electrocoagulation: preliminary results. Gastrointest Endos 1996;44:532–535.

138. Hofstetter WA, Peters JH, DeMeester TR, et al. Long term outcome of antireflux surgery in patients

with Barrett’s esophagus. Ann Surg 2001;234:532–539.

139. Lord RV, DeMeester SR, Peters JH, et al. Hiatal hernia, lower esophageal sphincter incompetence,

and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J

Gastrointest Surg 2009;13:602–610.

140. Farrell TM, Smith CD, Metreveli RE, et al. Fundoplication provides effective and durable symptom

relief in patients with Barrett’s esophagus. Am J Surg 1999;178:18–21.

141. Oelschlager BK, Barreca M, Chang L, et al. Clinical and pathologic response of Barrett’s esophagus

to laparoscopic antireflux surgery. Ann Surg 2003;238:458–466.

142. Mehta S, Bennett J, Mahon D, et al. Prospective trial of laparoscopic Nissen fundoplication versus

proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up. J

Gastrointest Surg 2006;10:1312–1316.

143. Dallemagne B, Weerts J, Markiewicz S, et al. Clinical results of laparoscopic fundoplication at ten

years after surgery. Surg Endosc 2006;20:159–165.

1101

144. Morgenthal CB, Shane MD, Stival A, et al. The durability of laparoscopic Nissen fundoplication: 11-

year outcomes. J Gastrointest Surg 2007;11:693–700.

145. Wijnhoven BP, Lally CJ, Kelly JJ, et al. Use of antireflux medication after antireflux surgery. J

Gastrointest Surg 2008;12:510–517.

146. Lurje G, Vallbohmer D, Collet PH, et al. COX-2 mRNA expression is significantly increased in acidexposed compared to nonexposed squamous epithelium in gastroesophageal reflux disease. J

Gastrointest Surg 2007;11:1105–1111.

147. Vallböhmer D, DeMeester SR, Oh DS, et al. Antireflux surgery normalizes cyclooxygenase-2

expression in squamous epithelium of the distal esophagus. Am J Gastroenterol 2006;101:1458–1466.

148. Oh DS, DeMeester SR, Vallböhmer D, et al. Reduction of interleukin 8 gene expression in reflux

esophagitis and Barrett’s esophagus with antireflux surgery. Arch Surg 2007;142:554–559.

149. Altorki NK, Sunagawa M, Little AG, et al. High-grade dysplasia in the columnar-lined esophagus.

Am J Surg 1991;161:99–100.

150. Pera M, Trastek VF, Carpenter HA, et al. Barrett’s esophagus with high grade dysplasia: an

indication for esophagectomy. Ann Thorac Surg 1992;54:199–204.

151. Ferguson MK, Naunheim KS. Resection for Barrett’s mucosa with high-grade dysplasia: implications

for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997;114:824–829.

152. www.drugs.com. Accessed September 12, 2006.

153. www.rxlist.com. Accessed September 12, 2006.

154. Sandmark S, Carlsson R, Fausa O, et al. Omeprazole or ranitidine in the treatment of reflux

esophagitis. Scand J Gastroenterol 1988;23:625–632.

155. Katzka DA, Paoletti V, Leite L, et al. Prolonged ambulatory pH monitoring in patients with

persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need

for more aggressive anti-reflux therapy. Am J Gastroenterol 1996;91:2110–2113.

156. Peghini PL, Katz PO, Bracy NA, et al. Nocturnal recovery of gastric acid secretion with twice-daily

dosing of proton pump inhibitors. Am J Gastroenterol 1998;93:763–767.

157. Laheij RJ, Sturkenboom MC, Hassing R-J, et al. Risk of community-acquired pneumonia and use of

gastric acid-suppressive drugs. JAMA 2004; 292:1955–1960.

158. Yang Y-X, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and the risk of hip

fracture. JAMA 2006;296:2947–2953.

159. Roux C, Briot K, Gossec L, et al. Increase in vertebral fracture risk in postmenopausal women using

omeprazole. Calcif Tissue Int 2009;84:13–19.

160. Targownik LE, Lix LM, Metge CJ, et al. Use of proton pump inhibitors and risk of osteoporosisrelated fractures. CMAJ 2008;179:319–326.

161. Campos GM, Peters JH, DeMeester TR, et al. The pattern of esophageal acid exposure in GERD

influences the severity of the disease. Arch Surg 1999;134:882–887; discussion 887–888.

162. Finks JF, Wei Y, Birkmeyer JD. The rise and fall of antireflux surgery in the United States. Surg

Endosc 2006;20:1698–1701.

163. Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of the factors predicting

outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999;3:292–300.

164. Miller FA. Utilization of inlying pH-probe for evaluation of acid-peptic diathesis. Arch Surg

1964;89:199–203.

165. Johnson LF, DeMeester TR. Development of the 24-hour intraesophageal pH monitoring composite

scoring system. J Clin Gastroenterol 1986; 8(suppl 1):52–58.

166. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal

values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol

1992;87:1102–1111.

167. Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless

system. Am J Gastroenterol 2003;98:740–749.

168. Wenner J, Johansson J, Johnsson F, et al. Optimal thresholds and discriminatory power of 48-h

wireless esophageal pH monitoring in the diagnosis of GERD. Am J Gastroenterol 2007;102:1862–

1869.

169. Tutuian R, Vela MF, Shay SS, et al. Multichannel intraluminal impedance in esophageal function

1102

testing and gastroesophageal reflux monitoring. J Clin Gastroenterol 2003;37:206–215.

170. Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH

measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology

2001;120:1599–1606.

171. Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH

monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen

fundoplication. Br J Surg 2006; 93:1483–1487.

172. Gruebel C, Linke G, Tutuian R, et al. Prospective study examining the impact of multichannel

intraluminal impedance on antireflux surgery. Surg Endosc 2008;22:1241–1247.

173. Gastal OL, Hagen JA, Peters JH, et al. Short esophagus: analysis of predictors and clinical

implications. Arch Surg 1999;134:633–636; discussion 637–638.

174. Ritter MP, Peters JH, DeMeester TR, et al. Treatment of advanced gastroesophageal reflux disease

with Collis gastroplasty and Belsey partial fundoplication. Arch Surg 1998;133:523.

175. DeMeester SR, Sillin LF, Lin HW, et al. Increasing esophageal length: a comparison of laparoscopic

versus transthoracic esophageal mobilization with and without vagal trunk division in pigs. J Am

Coll Surg 2003;197:558–564.

176. Stein HJ, Feussner H, Siewart JR. Failure of antireflux surgery: causes and management. Am J Surg

1996;171:36.

177. Johnson WE, Hagen JA, DeMeester TR, et al. Outcome of respiratory symptoms after antireflux

surgery on patients with gastroesophageal reflux disease. Arch Surg 1996;131:489–492.

178. Salvador R, Dubecz A, Polomsky M, et al. A new era in esophageal diagnostics: the image-based

paradigm of high-resolution manometry. J Am Coll Surg 2009;208:1034–1044.

179. Salvador R, Watson TJ, Herbella F, et al. Association of gastroesophageal reflux and O2

desaturation: a novel study of simultaneous 24-h MII-pH and continuous pulse oximetry. J

Gastrointest Surg 2009;13:854–861.

180. Potluri S, Friedenberg F, Parkman HP, et al. Comparison of a salivary/sputum pepsin assay with

24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus,

oropharynx, and lung. Dig Dis Sci 2003;48:1813–1817.

181. Johnston N, Knight J, Dettmar PW, et al. Pepsin and carbonic anhydrase isoenzyme III as

diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004;114:2129–2134.

182. Kim TH, Lee KJ, Yeo M, et al. Pepsin detection in the sputum/saliva for the diagnosis of

gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal

reflux disease symptoms. Digestion 2008;77:201–206.

183. Watson DI, Jamieson GG, Pike GK, et al. Prospective randomized double-blind trial between

laparoscopic Nissen and anterior partial fundoplication. Br J Surg 1999;86:123–130.

184. Laws HL, Clements RH, Swillie CM. A randomized, prospective comparison of the Nissen

fundoplication versus the Toupet fundoplication for gastroesophageal reflux disease. Ann Surg

1997;225:647.

185. Hagedorn C, Lonroth H, Rydberg L, et al. Long-term efficacy of total (Nissen-Rossetti) and

posterior partial (Toupet) fundoplication: results of a randomized clinical trial. J Gastrointest Surg

2002;6:540–545.

186. Cai W, Watson DI, Lally CJ, et al. Ten-year clinical outcome of a prospective randomized clinical

trial of laparoscopic Nissen versus anterior 180° partial fundoplication. Br J Surg 2008;95:1501–

1505.

187. Jobe BA, Wallace J, Hansen PD, et al. Evaluation of laparoscopic Toupet fundoplication as a

primary repair for all patients with medically resistant gastroesophageal reflux. Surg Endosc

1997;11:1080–1083.

188. Bell RC, Hanna P, Mills MR, et al. Patterns of success and failure with laparoscopic partial

fundoplication. Surg Endosc 1999;13:1189–1194.

189. Patti MG, Robinson T, Galvani C, et al. Total fundoplication is superior to partial fundoplication

even when esophageal peristalsis is weak. J Am Coll Surg 2004;198:863.

190. Horvath KD, Jobe BA, Herron DM, et al. Laparoscopic Toupet is an inadequate procedure for

patients with severe reflux disease. J Gastrointest Surg 1999;3:583–591.

191. Watson DI, Jamieson GG, Devitt PG, et al. Paraoesophageal hiatus hernia: an important

1103

complication of laparoscopic Nissen fundoplication. Br J Surg 1995;82:521–523.

192. Terry ML, Vernon A, Hunter JG. Stapled-wedge Collis gastroplasty for the shortened esophagus.

Am J Surg 2004;188:195–199.

193. Carlson MA, Frantzides CT. Complications and results of primary minimally invasive antireflux

procedures: a review of 10,735 reported cases. J Am Coll Surg 2001;193:429–439.

194. Hinder RA, Filipi CJ, Wetscher G, et al. Laparoscopic Nissen fundoplication is an effective

treatment for gastroesophageal reflux disease. Ann Surg 1994;220:472.

195. DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease

– evaluation of primary repair in 100 consecutive patients. Ann Surg 1986;204:9–20.

196. Bammer T, Hinder RA, Klaus A, et al. Five- to eight-year outcome of the first laparoscopic Nissen

fundoplications. J Gastrointest Surg 2001;5:42–48.

197. Granderath FA, Kamolz T, Schweiger UM, et al. Long-term results of laparoscopic antireflux

surgery: surgical outcomes and analysis of failure after 500 laparoscopic antireflux procedures. Surg

Endosc 2002;16:753–757.

198. Catarci M, Gentileschi P, Papi C, et al. Evidence-based appraisal of antireflux fundoplication. Ann

Surg 2004;239:325–337.

199. Lundell L, Miettinen P, Myrvold HE, et al. Continued (5-year) follow-up of a randomized clinical

study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll

Surg 2001;192:172.

200. Nilsson G, Wenner J, Larsson S, et al. Randomized clinical trial of laparoscopic versus open

fundoplication for gastroesophageal reflux. Br J Surg 2004;91:552–559.

201. Finlayson SR, Laycock WS, Birkmeyer JD. National trends in utilization and outcomes of antireflux

surgery. Surg Endosc 2003;17:864–867.

202. So JB, Zeitels SM, Rattner DW. Outcomes of atypical symptoms attributed to gastroesophageal

reflux treated by laparoscopic fundoplication. Surgery 1998;124:28–32.

203. Lundell L, Miettinen P, Myrvold HE, et al. Seven-year follow-up of a randomized clinical trial

comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg

2007;94:198–203.

204. Lundell L, Attwood SE, Ell C, et al. Comparing laparoscopic antireflux surgery with esomeprazole

in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim

analysis of the LOTUS trial. Gut 2008;57:1207–1213.

205. Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux

disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study

Group. N Engl J Med 1992;326:786–792.

206. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for

gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001;285:2331–

2338.

207. Lord RV, Kaminski A, Oberg S, et al. Absence of gastroesophageal reflux disease in a majority of

patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg

2002;6:3.

208. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996;334:835–840.

209. Trus TL, Laycock WS, Waring JP, et al. Improvement in quality of life measures following

laparoscopic antireflux surgery. Ann Surg 1999;229:331–336.

210. Glise H, Hallerbäck B, Johansson B. Quality-of-life assessments in evaluation of laparoscopic

Rossetti fundoplication. Surg Endosc 1995;9:183.

211. Velonovich V, Vallance SR, Gusz JR, et al. Quality of life scale for gastroesophageal reflux disease.

J Am Coll Surg 1996;183:217–224.

212. Fernando HC, Schauer PR, Rosenblatt M, et al. Quality of life after antireflux surgery compared

with nonoperative management for severe gastroesophageal reflux disease. J Am Coll Surg

2002;194:23–27.

213. Polomsky M, Siddall KA, Salvador R, et al. Association of kyphosis and spinal skeletal abnormalities

with intrathoracic stomach: a link toward understanding its pathogenesis. J Am Coll Surg

2009;208:562–569.

214. Hashemi M, Peters JH, DeMeester TR, et al. Laparoscopic repair of large type III hiatal hernia:

1104